| DGSCX | RSLDX | DGSCX / RSLDX | |
| Total Expense Ratio | 1.28 | 0.80 | 160% |
| Annual Report Gross Expense Ratio | 1.35 | 0.80 | 169% |
| Fund Existence | 29 years | 10 years | - |
| Gain YTD | -0.703 | 13.225 | -5% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 38.9M | 82.3B | 0% |
| Annual Yield % from dividends | 1.02 | 0.76 | 134% |
| Returns for 1 year | -12.53 | 6.84 | -183% |
| Returns for 3 years | 10.42 | 31.03 | 34% |
| Returns for 5 years | -23.93 | 3.56 | -671% |
| Returns for 10 years | -16.45 | 65.95 | -25% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GHYG | 45.96 | 0.13 | +0.28% |
| iShares US & Intl High Yield Corp Bd ETF | |||
| QMMY | 24.85 | 0.06 | +0.22% |
| FT Vest Nasdaq-100 Mod Buffr ETF - May | |||
| RSPE | 29.33 | N/A | +0.01% |
| Invesco ESG S&P 500 Equal Weight ETF | |||
| VOE | 175.69 | -0.59 | -0.33% |
| Vanguard Mid-Cap Value ETF | |||
| LABU | 147.82 | -5.53 | -3.61% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||